Back

Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) trial: Primary Results.

27 August 2017 (16:05 - 16:25)
Organised by:
Congress Presentation Part of: Meet the Trialists - COMPASS Primary cardiovascular prevention: interventions and outcomes ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor John William Eikelboom

McMaster University, Hamilton (Canada)

Access the full session

Session thumbnail
Meet the Trialists - COMPASS

The Event

Event poster

ESC Congress 2017

27 August 2017 16:05 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of low-dose rivaroxaban on top of aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial
30 August 2020
thumbnail
ESC TV Today
Episode 4: Heart disease in dialysis patients - Substance abuse and heart disease
7 November 2024
thumbnail
Congress Presentation
Year-to-year change of antithrombotic strategy and clinical outcomes of atrial fibrillation patients with vascular disease in this decade: The Fushimi AF Registry.
28 August 2023
thumbnail
Congress Presentation
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources